GO:0051977 lysophospholipid transport: Lysosomal Lipid Export Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051977 lysophospholipid transport describes the directed movement of lysophospholipids (phospholipids missing one fatty acyl chain) into, out of, or within cells by transporters or pores.
• The lysosomal exporter SPNS1 is the best-characterized protein mediating lysophospholipid transport from the lysosome to the cytosol, and its structure and mechanism have been resolved.
• Loss-of-function SPNS1 variants cause a multiorgan disease in humans and implicate lysophospholipid transport in mTOR-regulated lipid homeostasis.
• SPNS2, a related Spinster-family exporter, transports sphingosine-1-phosphate (S1P), a lysophospholipid-like signaling lipid, and its structure and inhibition are well studied.
• Mfsd2a is a transporter for the omega-3 fatty acid docosahexaenoic acid (DHA) in the form of lysophosphatidylcholine, linking lysophospholipid transport to brain lipid supply.
• Lysophospholipid transport is experimentally tractable using E. coli spheroplasts, structural biology, and CRISPR-engineered cell models.
Description
Lysophospholipid transport (GO:0051977) is the directed movement of lysophospholipids into, out of, or within a cell, or between cells, by means of a transporter or pore. A lysophospholipid is a phospholipid that lacks one of its two fatty acyl chains; such molecules are generated as intermediates during the digestion of dietary and biliary phospholipids and also arise from phospholipase A activity on membrane phospholipids. Because lysophospholipids are amphipathic and can disrupt membranes, their distribution must be tightly controlled, and dedicated transport proteins are required to move them between compartments and across the plasma membrane. The best-characterized lysophospholipid transporter is SPNS1, a lysosomal membrane protein that exports lysophospholipids from the lysosome to the cytosol. Structural and biochemical work has defined how SPNS1 recognizes its lipid substrates and how disease-causing mutations impair transport. A related Spinster-family member, SPNS2, exports sphingosine-1-phosphate (S1P), a lysophospholipid-like signaling molecule, and its structure and inhibition have been resolved. In addition, Mfsd2a transports lysophosphatidylcholine carrying docosahexaenoic acid (DHA) into the brain, connecting lysophospholipid transport to essential fatty acid delivery. For researchers, GO:0051977 matters because defects in lysophospholipid transport are now linked to human multiorgan disease and to dysregulated mTOR-dependent lipid homeostasis. The pathway also intersects with secretory diarrhoea mechanisms and with cholesterol transport pathways that depend on S1P signalling. This article summarizes the definition, mechanism, key genes, disease links, and experimental methods for studying lysophospholipid transport, with a focus on CRISPR-based models.
lysophospholipid transport At A Glance
| GO ID | GO:0051977 |
|---|---|
| GO term | lysophospholipid transport |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Directed movement of lysophospholipids across membranes by transporters or pores |
| Representative transporters | SPNS1, SPNS2, Mfsd2a |
| Substrate class | Lysophospholipids (phospholipids lacking one fatty acyl chain) |
| Key compartment | Lysosome, plasma membrane, and cytosol |
| Disease relevance | Multiorgan disease, mTOR-regulated lipid homeostasis, neurological lipid supply |
What Is GO:0051977?
In simple terms, GO:0051977 lysophospholipid transport is the process by which cells move lysophospholipids from one place to another using dedicated transporter proteins or pores. The Gene Ontology defines it as the directed movement of phospholipids into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore, where a lysophospholipid is a phospholipid that lacks one of its fatty acyl chains and is an intermediate formed during digestion of dietary and biliary phospholipids. This biological process therefore covers the translocation step itself, including lysosomal export by SPNS1, plasma-membrane export of S1P by SPNS2, and uptake of lysophosphatidylcholine by Mfsd2a.
Why Is lysophospholipid transport Important in Cell Biology?
Lysophospholipid transport is important because lysophospholipids are bioactive and membrane-perturbing molecules whose levels and locations must be precisely controlled. The lysosomal exporter SPNS1 is required for normal lipid homeostasis, and human SPNS1 variants cause a multiorgan disease that implicates lysophospholipid transport in mTOR-regulated lipid homeostasis. The structural basis of Spns1-mediated lysophospholipid transport from the lysosome has been defined, providing a mechanistic framework for understanding how mutations disrupt transport. Related transporters such as SPNS2 and Mfsd2a extend the pathway to S1P signalling and brain DHA delivery, linking GO:0051977 to immunity, vascular biology, and neurodevelopment. Because these processes intersect with diarrhoea mechanisms and cholesterol transport, lysophospholipid transport is a research area with broad physiological and therapeutic relevance.
• Defines a distinct lipid-trafficking step required for lysosomal lipid clearance and cytosolic lipid distribution.
• Human SPNS1 variants cause multiorgan disease, establishing lysophospholipid transport as clinically essential.
• Connects lysophospholipid export to mTOR-regulated lipid homeostasis and cellular growth control.
• SPNS2-mediated S1P export regulates a lysophospholipid-like signalling lipid with roles in immunity and vascular biology.
• Mfsd2a-dependent lysophosphatidylcholine transport supplies DHA to the brain, linking the term to neurodevelopment.
• Provides a mechanistic target for understanding secretory diarrhoea and electrolyte transport.
• Intersects with S1P signalling and HDL-derived cholesterol transport, connecting lipid transport pathways.
• Offers tractable experimental systems, including E. coli spheroplasts for transport assays.
• Supports structure-guided interpretation of disease mutations in Spinster-family transporters.
• Enables CRISPR-based dissection of transporter function in human cell models.
What Happens During lysophospholipid transport?
Substrate generation and recognition
In simple terms: First, lysophospholipids are made and then recognized by a transporter.
Lysophospholipids are phospholipids that lack one fatty acyl chain and are intermediates formed during digestion of dietary and biliary phospholipids. They can also be generated in cells and must be recognized by dedicated transporters. Structural work on Spns1 has defined how the transporter engages lysophospholipid substrates, providing a molecular basis for substrate recognition during lysophospholipid transport.
Lysosomal export by SPNS1
In simple terms: SPNS1 acts as a door that lets lysophospholipids leave the lysosome.
SPNS1 mediates lysophospholipid transport from the lysosome to the cytosol, and the molecular basis of this export has been resolved. This step is critical because lysosomal accumulation of lysophospholipids is harmful, and SPNS1 loss impairs lipid homeostasis. Disease-associated SPNS1 variants disrupt this transport step and cause multiorgan disease, directly linking the transport reaction to human pathology.
Plasma-membrane export of S1P by SPNS2
In simple terms: A related transporter, SPNS2, pushes a lysophospholipid-like signal out of the cell.
SPNS2 is a Spinster-family exporter that transports sphingosine-1-phosphate (S1P), a lysophospholipid-like signalling lipid. Structural and functional studies have defined how SPNS2 recognizes and exports S1P and how inhibitors block this activity. This export step connects lysophospholipid transport to extracellular signalling and to S1P-dependent processes such as HDL-derived cholesterol transport.
Uptake of lysophosphatidylcholine by Mfsd2a
In simple terms: Mfsd2a brings a specific lysophospholipid carrying DHA into cells.
Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid (DHA), which it imports in the form of lysophosphatidylcholine. This uptake step is a clear example of lysophospholipid transport at the plasma membrane and links GO:0051977 to brain lipid supply and neurodevelopment.
Integration with mTOR-regulated lipid homeostasis
In simple terms: The transport step feeds into a master growth-control pathway.
SPNS1 variants that impair lysophospholipid transport cause multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis. This places GO:0051977 upstream of, or integrated with, nutrient-sensing and growth-control signalling, and it explains why transport defects have systemic consequences.
Key Genes Involved in GO:0051977 lysophospholipid transport
The following genes and proteins are the principal experimental handles for studying GO:0051977 lysophospholipid transport, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SPNS1 | Lysosomal lysophospholipid exporter | Core transporter for GO:0051977; structure and disease variants defined |
| SPNS2 | S1P exporter of the Spinster family | Related lysophospholipid-like transport; structure and inhibition resolved |
| MFSD2A | Lysophosphatidylcholine/DHA transporter | Plasma-membrane lysophospholipid uptake; brain lipid supply |
| SLC family members | Candidate lipid transporters | Potential additional lysophospholipid transport activities |
| ABCA1 | Cholesterol and phospholipid efflux | Lipid transport context linked to S1P signalling |
| ABCG1 | Cholesterol efflux | HDL-related lipid transport context |
| APOA1 | HDL component | HDL-derived lipid transport context |
| CFTR | Chloride channel | Secretory diarrhoea mechanisms intersecting with lipid transport |
| MTOR | Nutrient-sensing kinase | Lipid homeostasis pathway linked to SPNS1 function |
| LPL | Lipoprotein lipase | Dietary and biliary phospholipid digestion context |
| PLA2G family | Phospholipases | Generate lysophospholipids as transport substrates |
| LCAT | Phospholipid remodeling enzyme | HDL phospholipid metabolism context |
| S1PR1 | S1P receptor | Readout of SPNS2-mediated S1P export |
| E-SYT1 | Extended synaptotagmin | S1P signalling and cholesterol transport link |
| NPC1 | Lysosomal lipid exporter | Lysosomal lipid transport comparison |
| LAMP1 | Lysosomal marker | Localization control for SPNS1 studies |
How Is lysophospholipid transport Regulated?
Lysophospholipid transport is regulated at multiple levels. SPNS1-mediated lysophospholipid export is critical for mTOR-regulated lipid homeostasis, so the pathway is functionally coupled to nutrient-sensing signalling. The activity of Spinster-family transporters is also controlled by their substrate availability and by structural determinants of substrate recognition, as shown for Spns1 and SPNS2. In addition, S1P signalling downstream of SPNS2 can activate E-Syt1 to facilitate HDL-derived cholesterol transport, indicating that lysophospholipid transport is embedded in a broader regulatory network of lipid trafficking. Disease-associated SPNS1 variants provide natural perturbations that reveal how loss of transport deregulates these homeostatic circuits.
lysophospholipid transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SPNS1 | Multiorgan disease; mTOR-regulated lipid homeostasis | SPNS1 knockout and point-mutation knock-in cell lines |
| SPNS2 | S1P signalling; immune and vascular biology | SPNS2 knockout with S1P export assays |
| MFSD2A | Brain DHA supply; neurodevelopment | MFSD2A knockout and lysophosphatidylcholine uptake assays |
| ABCA1/ABCG1 | HDL-derived cholesterol transport | Knockout models with S1P/E-Syt1 readouts |
| CFTR | Secretory diarrhoea | Epithelial transport models |
SPNS1 variants and multiorgan disease
Human SPNS1 variants cause a multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis. This establishes GO:0051977 as a clinically relevant process and provides a direct genotype-to-phenotype link for loss of lysosomal lysophospholipid export. The structural basis of Spns1-mediated transport helps explain how these variants impair transporter function.
S1P signalling, immunity, and vascular biology
SPNS2 exports sphingosine-1-phosphate, a lysophospholipid-like signalling lipid, and its structure and inhibition have been characterized. Because S1P signalling activates E-Syt1 to facilitate HDL-derived cholesterol transport, defects in this arm of lysophospholipid transport can affect lipid trafficking and related vascular and immune processes.
Brain lipid supply and neurodevelopment
Mfsd2a transports lysophosphatidylcholine carrying docosahexaenoic acid into cells, linking lysophospholipid transport to brain lipid supply. Disruption of this uptake pathway is therefore relevant to neurodevelopmental and neurological phenotypes associated with impaired DHA delivery.
Secretory diarrhoea and epithelial transport
Secretory diarrhoea mechanisms involve coordinated ion and lipid transport in the gut, and reviews of these mechanisms provide context for how lysophospholipid transport may intersect with epithelial physiology. This connection broadens the disease relevance of GO:0051977 beyond rare genetic disorders.
From lysophospholipid transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is SPNS1 required for lysosomal lysophospholipid export? | SPNS1 knockout cell line with lipid transport assay |
| How do disease variants impair transport? | SPNS1 point-mutation knock-in lines |
| Where does SPNS1 localize and traffic? | Tagged knock-in SPNS1 with imaging |
| Does SPNS2 export S1P in a specific cell type? | SPNS2 knockout and overexpression lines |
| Does Mfsd2a mediate lysophosphatidylcholine uptake? | MFSD2A knockout and overexpression lines |
| Which genes modify lysophospholipid transport? | CRISPR library screening in lipid-reporting cells |
How to Study the lysophospholipid transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| E. coli spheroplast transport assay | Direct lysophospholipid transport activity | Validate candidate transporters |
| Cryo-EM / structural biology | Transporter structure and substrate binding | Mechanistic interpretation of Spns1/SPNS2 |
| Lipidomics | Changes in lysophospholipid and lipid pools | Assess transport-dependent lipid homeostasis |
| Fluorescence imaging | Transporter localization and organelle distribution | Confirm lysosomal or plasma-membrane transport |
| S1P export assays | Extracellular S1P levels | Measure SPNS2 activity and inhibition |
| DHA uptake assays | Lysophosphatidylcholine/DHA import | Test Mfsd2a function |
| mTOR pathway readouts | Signalling downstream of lipid homeostasis | Link transport to growth control |
| CRISPR knockout/knock-in | Causal gene function | Build isogenic transport models |
Transport assays using E. coli spheroplasts
Lysophospholipid transport across membranes can be measured using Escherichia coli spheroplasts, a method developed to quantify transport activity directly. This approach is useful for validating whether a candidate transporter moves lysophospholipids and for comparing wild-type and mutant proteins.
Structural biology of Spinster-family transporters
Structural and functional studies of Spns1 and SPNS2 have defined substrate recognition and transport mechanisms. These structures provide templates for interpreting disease variants and for designing transport assays.
Lipidomics and metabolic readouts
Because lysophospholipid transport affects cellular lipid pools and mTOR-regulated lipid homeostasis, lipidomic profiling and pathway readouts are central methods. Comparing wild-type and mutant cells reveals which lipid species depend on the transporter.
Imaging and localization studies
Tagged transporters and organelle markers allow localization and trafficking studies of lysophospholipid transport proteins. Imaging complements biochemical transport assays by showing where transport occurs.
How CRISPR Can Be Used to Study GO:0051977 lysophospholipid transport
Knockout
CRISPR knockout of SPNS1, SPNS2, or MFSD2A removes the transporter and allows direct testing of whether lysophospholipid transport is required for a given readout. Knockout lines are the starting point for lipidomic and signalling assays that define the pathway.
Point Mutation
Point-mutation knock-in of disease-associated SPNS1 variants reproduces the human genotype and reveals how specific residues impair lysophospholipid transport. Such models are essential for distinguishing loss-of-function from other mechanisms.
Knock-in
Tagged knock-in of SPNS1 or SPNS2 enables localization, trafficking, and interaction studies under endogenous regulation. Knock-in reporters also allow transport activity to be monitored in living cells.
Overexpression
Overexpression of SPNS1, SPNS2, or MFSD2A increases transport capacity and is useful for biochemical assays and for testing substrate specificity. Overexpression combined with transport assays provides a sensitive readout of transporter function.
How EDITGENE Supports lysophospholipid transport Research
Researchers studying lysophospholipid transport-related genes often need to determine whether a candidate gene is causally involved in lipid movement, how disease variants alter transporter function, and which pathways depend on the transport step. EDITGENE provides CRISPR-engineered cell models and screening services designed to answer these questions with isogenic, publication-ready systems.
Contact EDITGENE today to design your custom CRISPR model for lysophospholipid transport research.
Frequently Asked Questions About lysophospholipid transport
What is lysophospholipid transport?
Lysophospholipid transport (GO:0051977) is the directed movement of lysophospholipids into, out of, or within a cell, or between cells, by means of a transporter or pore.
What genes are involved in lysophospholipid transport?
Key genes include SPNS1, which exports lysophospholipids from the lysosome, SPNS2, which exports S1P, and MFSD2A, which imports lysophosphatidylcholine carrying DHA.
What is the function of SPNS1 in lysophospholipid transport?
SPNS1 mediates lysophospholipid transport from the lysosome to the cytosol, and its structure and disease variants have been characterized.
How is lysophospholipid transport linked to disease?
SPNS1 variants cause a multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis.
What is the role of SPNS2 in lipid transport?
SPNS2 exports sphingosine-1-phosphate, a lysophospholipid-like signalling lipid, and its structure and inhibition have been resolved.
How does Mfsd2a relate to lysophospholipid transport?
Mfsd2a transports lysophosphatidylcholine carrying docosahexaenoic acid, linking lysophospholipid transport to brain lipid supply.
How can lysophospholipid transport be measured experimentally?
Transport can be measured using E. coli spheroplast assays, structural methods, lipidomics, and imaging of tagged transporters.
Which GO ID corresponds to lysophospholipid transport?
The Gene Ontology ID for lysophospholipid transport is GO:0051977, a biological_process term.
What cell models are used to study lysophospholipid transport?
CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression cell lines of SPNS1, SPNS2, and MFSD2A are commonly used.
Why is lysophospholipid transport important for cell biology?
It controls the distribution of bioactive lysophospholipids, supports lysosomal lipid clearance, and integrates with mTOR-regulated lipid homeostasis and S1P signalling.
Conclusion
GO:0051977 lysophospholipid transport defines a focused but physiologically central process: the transporter-mediated movement of lysophospholipids across cellular membranes. Work on SPNS1 has revealed the structural and mechanistic basis of lysosomal lysophospholipid export and linked transport defects to human multiorgan disease and mTOR-regulated lipid homeostasis. Related transporters SPNS2 and Mfsd2a extend the pathway to S1P signalling and brain DHA supply, connecting lysophospholipid transport to immunity, vascular biology, and neurodevelopment. For researchers, the pathway is experimentally accessible through transport assays, structural biology, lipidomics, imaging, and CRISPR-engineered cell models. Isogenic knockout, point-mutation, knock-in, and overexpression systems allow causal questions about lysophospholipid transport to be answered with precision, making GO:0051977 a tractable and clinically relevant research target.
References
- 1. Thiagarajah JR et al.. 2015. Secretory diarrhoea: mechanisms and emerging therapies.. Nat Rev Gastroenterol Hepatol 12(8):446-57 PMID: 26122478
- 2. Chen H et al.. 2025. Molecular basis of Spns1-mediated lysophospholipid transport from the lysosome.. Proc Natl Acad Sci U S A 122(1):e2409596121 PMID: 39739806
- 3. He M et al.. 2025. SPNS1 variants cause multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis.. J Clin Invest 135(17) PMID: 40608416
- 4. Lin Y et al.. 2019. Measurement of Lysophospholipid Transport Across the Membrane Using Escherichia coli Spheroplasts.. Methods Mol Biol 1949:165-180 PMID: 30790256
- 5. Chen H et al.. 2023. Structural and functional insights into Spns2-mediated transport of sphingosine-1-phosphate.. Cell 186(12):2644-2655.e16 PMID: 37224812
- 6. Li HZ et al.. 2025. Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2.. Nat Commun 16(1):721 PMID: 39820269
- 7. Nguyen LN et al.. 2014. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid.. Nature 509(7501):503-6 PMID: 24828044
- 8. Xu Z et al.. 2025. Sphingosine-1-phosphate signalling activates E-Syt1 to facilitate HDL-derived cholesterol transport.. Nat Cell Biol 27(6):918-930 PMID: 40437229
